Champions Oncology, Inc. (CSBR) Financials

CSBR Assets vs Liabilities
DateAssetsLiabilities
Jan. 31, 2026 28.4 million 24.1 million
Oct. 31, 2025 30.2 million 25.9 million
July 31, 2025 30.5 million 27.0 million
April 30, 2025 32.3 million 28.6 million

CSBR Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
Jan. 31, 2026 -1.4 million 423000
Oct. 31, 2025 -2.0 million 249000
July 31, 2025 554000 208000
April 30, 2025 6.6 million 131000

CSBR Net Income

No data available :(

CSBR Cash and Debt
Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
Jan. 31, 2026 7.1 million 3.4 million 3.4 million
Oct. 31, 2025 8.5 million 3.7 million 5.3 million
July 31, 2025 10.3 million 4.2 million 5.8 million
April 30, 2025 9.8 million 4.6 million 6.1 million

CSBR Shares Outstanding
Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
Jan. 31, 2026 13.9 million
Oct. 31, 2025 14.5 million
July 31, 2025 13.8 million
April 30, 2025 13.8 million

CSBR Expenses
Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
Jan. 31, 2026 37000 2.3 million 5.6 million 2.7 million
Oct. 31, 2025 242000 2.6 million 5.0 million 2.0 million
July 31, 2025 46000 2.1 million 4.1 million 1.9 million
April 30, 2025 253000 2.0 million 4.4 million 2.3 million

CSBR Cost of Revenue
Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
Jan. 31, 2026 16.6 million 9.2 million
Oct. 31, 2025 15.0 million 7.6 million
July 31, 2025 14.0 million 8.4 million
April 30, 2025 12.4 million 7.7 million

CSBR Revenue by Segment
Graph available only for paid members. Upgrade to see it.

CSBR

Price: $6.32

52 week price:
5.50
9.63

Earnings Per Share: -0.18 USD

Exchange: NCM

Sector: Healthcare

Industry: Biotechnology

Country: United States

Volume: 4300

Ebitda: -4.7 million

Market Capitalization: 78.5 million

Links: